Greenwich LifeSciences, Inc. Insider Transactions
Greenwich LifeSciences, Inc. Insider Trades History
Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
---|---|---|---|---|---|---|---|
Thompson Jaye
VP Clinical Reg Affairs |
Buy | 250 @ $9.49 | $2,373 | 259,248 | 07/13/2023 | 07/17/2023 | |
Patel Snehal
CEO |
Buy | 1,000 @ $11.69 | $11,690 | 5,287,177 | 05/17/2023 | 05/18/2023 | |
Thompson Jaye
VP Clinical Reg Affairs |
Buy | 250 @ $11.22 | $2,805 | 258,998 | 04/28/2023 | 05/02/2023 | |
Patel Snehal
CEO |
Buy | 7,000 @ $11.10 | $77,700 | 5,286,177 | 04/19/2023 | 04/21/2023 | |
Patel Snehal
CEO |
Buy | 2,000 @ $11.12 | $22,240 | 5,279,177 | 04/18/2023 | 04/20/2023 | |
Thompson Jaye
VP Clinical Reg Affairs |
Buy | 1,000 @ $11.87 | $11,870 | 258,745 | 04/11/2023 | 04/12/2023 | |
Patel Snehal
CEO |
Buy | 5,000 @ $12.42 | $62,100 | 5,271,177 | 04/11/2023 | 04/12/2023 | |
Thompson Jaye
VP Clinical Reg Affairs |
Buy | 250 @ $12.71 | $3,178 | 257,745 | 03/15/2023 | 03/16/2023 |
Greenwich LifeSciences, Inc. FAQ's
The list of insiders at Greenwich LifeSciences, Inc. includes Patel Snehal.
Insiders have purchased a total of 7,000 Greenwich LifeSciences, Inc. shares in the last 12 months for a total of 133,710.
The following insiders have purchased Greenwich LifeSciences, Inc. shares in the last 12 months: Patel Snehal ($133,710),